TELL ME MORE

ABOUT THIS CLINICAL TRIAL for IBS-C in Children

This is an Efficacy and Safety Study of an investigational medicine for Irritable Bowel Syndrom with Constipation in patients ages 6 – 17 years.

 

Irritable Bowel with Constipation (IBS-C in Children)

Clinical Trial for IBS-C in Children

Study Location(s): Bowling Green Kentucky and Evansville Indiana

Irritable bowel syndrome (IBS) is a group of symptoms that occur together, including repeated pain in the abdomen and changes in bowel movements, which may be diarrhea, constipation, or both. With IBS, a child has these symptoms without any visible signs of damage or disease in the digestive tract. Studies suggest that more than 5 percent of children may suffer with IBS.  This study evaluates efficacy and safety of a previously approved medication for adults in children ages 6 – 17 years. Click here for more information on IBS in childrend

There is no cost to participate.  Volunteers receive free investigational medicine and follow-up care.  No insurance needed.  Time and travel reimburrsement up to $350 may be available.

View More Studies

[table id=1 /]

Why are we asking for this information?

Baby’s due date/Birthday helps us ensure the diapers go to their intended recipients, expecting parents and newborns.  By registering for this giveaway you agree to let Qualmedica Reseasrch send information on infant formula and vaccine studies from time to time.  Click here for a complete listing of our privacy policy.

Pin It on Pinterest